Live tape
Top 8, mentions 7d29,477NVDA13,951 mentions▲ +0.04ANT4,236 mentions▲ +0.07GOOGL3,026 mentions▲ +0.04SPY2,311 mentions▲ +0.05QQQ1,824 mentions▲ +0.04SPCX1,578 mentions▲ +0.07AMD1,371 mentions▲ +0.06AAPL1,180 mentions▲ +0.04

Equity · Healthcare

REGN

NASDAQ

Regeneron Pharmaceuticals (REGN)

921.31 USD −0.25% vs prior close Nov 20, 2026
Regeneron Pharmaceuticals, Inc. price graph
52 sessions
1,000 700 24 Aug 20 Nov

The line runs 829 USD on 24 August through 921.31 USD on 20 November, on a scale from 700 to 1,000. Days the market did not trade hold the previous close, flat.

Market cap
97.9B USD
P/E (TTM)
20.4
Revenue, year to Dec 2025
14.3B USD
EPS, diluted, year to Dec 2025
41.48 USD
52-week range
600 USD – 973.81 USD
Avg volume
49.0K
Mentions, 30 days
7
Net sentiment
+0.18

as of Nov 20, 2026

Have Regeneron Pharmaceuticals (REGN) insiders bought or sold shares recently?

In the 90 days to 23 Nov 2026, Regeneron Pharmaceuticals insiders reported 16 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 10 Aug 2026, show no open-market purchase.

Form 4, 90 days to 23 Nov 2026, newest reported trade 17 Nov 2026

0buys
16sells
$59.16Mnet sold
17other filings
Have Regeneron Pharmaceuticals (REGN) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
17 Nov 2026MURPHY ANDREW JCo-Chief Scientific OfficerSell5,0114.8M USD
17 Nov 2026SING GEORGE LDirectorSell1,000958K USD
16 Nov 2026McCourt MarionEVP CommercialSell566544K USD
16 Nov 2026SING GEORGE LDirectorSell1,000960K USD
04 Nov 2026Pitofsky JasonSVP ControllerSell4,0623.8M USD
03 Nov 2026Zoghbi Huda YDirectorSell7,4397.2M USD
02 Nov 2026LAROSA JOSEPH JEVP General Counsel and SecretSell4,4664.3M USD
02 Nov 2026POON CHRISTINE ADirectorSell7,8307.6M USD
02 Nov 2026SING GEORGE LDirectorSell21,12920.4M USD
30 Oct 2026BROWN MICHAEL SDirectorSell1,9291.7M USD
30 Oct 2026Guarini KathrynDirectorSell400360K USD
30 Oct 2026McCourt MarionEVP CommercialSell1,132984K USD
Sold16 open-market sales62,857$59.16M

Showing the 12 most recent of 16 open-market trades in this window. The figures above count all of them.

17 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Regeneron Pharmaceuticals (REGN) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
16 Nov 2026MURPHY ANDREW JCo-Chief Scientific OfficerOption exercise17,0006.5M USD
16 Nov 2026MURPHY ANDREW JCo-Chief Scientific OfficerTax withheld11,98911.5M USD
04 Nov 2026Pitofsky JasonSVP ControllerOption exercise3,8832.5M USD
03 Nov 2026MURPHY ANDREW JCo-Chief Scientific OfficerGift1,054
03 Nov 2026Zoghbi Huda YDirectorOption exercise7,4392.8M USD
02 Nov 2026Fenimore Christopher R.EVP Finance CFOOption exercise6,0002.3M USD
02 Nov 2026Fenimore Christopher R.EVP Finance CFOTax withheld4,2434.0M USD
02 Nov 2026Fenimore Christopher R.EVP Finance CFOGift15
02 Nov 2026LAROSA JOSEPH JEVP General Counsel and SecretOption exercise12,2834.7M USD
02 Nov 2026LAROSA JOSEPH JEVP General Counsel and SecretTax withheld8,6868.3M USD
02 Nov 2026POON CHRISTINE ADirectorOption exercise7,8302.9M USD
02 Nov 2026SING GEORGE LDirectorOption exercise15,2695.8M USD

Showing the 12 most recent of 17 compensation filings in this window. The figures above count all of them.

Which funds hold Regeneron Pharmaceuticals (REGN)?

15 of the 45 institutional funds we track reported a Regeneron Pharmaceuticals position for the quarter ended 30 Sep 2026 — a combined 2.9B USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Regeneron Pharmaceuticals (REGN)?
FundPositionSharesValueShares q/q
AQR Capital ManagementHeld (±25%)1,311,729978.9M USD+16.5%
Two Sigma InvestmentsAdded869,505659.3M USD+32.5%
Citadel AdvisorsAdded352,728267.5M USD+512.3%
Man GroupTrimmed295,111223.8M USD−32.5%
Renaissance TechnologiesAdded272,218206.4M USD+83.7%
Marshall WaceAdded213,937162.2M USD+830.2%
Millennium ManagementHeld (±25%)147,538111.9M USD−10.6%
Point72 Asset ManagementNew position124,38094.3M USD
Bridgewater AssociatesAdded105,93480.3M USD+106.4%
D. E. Shaw & Co.Added58,63644.5M USD+52.4%

Showing the 10 largest of 15 reported positions. The figures above count all of them.

Have members of Congress traded Regeneron Pharmaceuticals (REGN)?

The most recent congressional trade disclosed in Regeneron Pharmaceuticals is a sale by Gilbert Ray Cisneros, Jr. (house, CA), dated 15 May 2026.

STOCK Act disclosures

Have members of Congress traded Regeneron Pharmaceuticals (REGN)?
TradedMemberTypeAmountFiled after
15 May 2026Gilbert Ray Cisneros, Jr.house · Democrat–CASale1K USD–15K USD24 days
18 Nov 2025Gilbert Ray Cisneros, Jr.house · Democrat–CAPurchase1K USD–15K USD27 days
15 May 2025Robert P. Bresnahan, Jr.house · Republican–PAPurchase1K USD–15K USD25 days
10 Apr 2025Byron Donaldshouse · Republican–FLSale1K USD–15K USD44 days
08 Apr 2025Robert P. Bresnahan, Jr.house · Republican–PASale1K USD–15K USD30 days
07 Apr 2025Jefferson Shrevehouse · Republican–INSale15K USD–50K USD31 days
01 Apr 2025Julie Johnsonhouse · Democrat–TXSale1K USD–15K USD43 days
25 Feb 2025Robert P. Bresnahan, Jr.house · Republican–PASale1K USD–15K USD30 days

Regeneron Pharmaceuticals (REGN) US federal contracts

US federal agencies committed 279.4M USD in contracts to Regeneron Pharmaceuticals (REGN) in fiscal 2026, the year to 30 Sep 2026.

USAspending.gov

Regeneron Pharmaceuticals (REGN) US federal contracts
Fiscal yearCommitted
Fiscal 2026 (Oct 2025 to Sep 2026)279.4M USD
Fiscal 2023 (Oct 2022 to Sep 2023)326.5M USD

Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.

What has been filed or recorded for Regeneron Pharmaceuticals (REGN)?

The filings we hold for Regeneron Pharmaceuticals, newest first: 6 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 29 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Regeneron Pharmaceuticals (REGN)?
And
29 Oct 2026Fails to deliverShares failed to deliver61 shares50K USD notional · <0.001% of shares out
27 Oct 2026Fails to deliverShares failed to deliver52 shares42K USD notional · <0.001% of shares out
23 Oct 2026Fails to deliverShares failed to deliver6 shares5K USD notional · <0.001% of shares out
22 Oct 2026Fails to deliverShares failed to deliver12 shares10K USD notional · <0.001% of shares out
16 Oct 2026Fails to deliverShares failed to deliver74 shares59K USD notional · <0.001% of shares out
15 Oct 2026Fails to deliverShares failed to deliver8 shares6K USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS 18.45 USD
30 Sep 2026FinancialsTotal assets44.4B USDat period end
30 Sep 2026FinancialsTotal equity33.5B USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 12.23 USD
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 6.75 USD
31 Dec 2025Annual reportFY 2025 reportedEPS 41.48 USD
31 Dec 2025FinancialsRevenue14.3B USDfiscal year
31 Dec 2025FinancialsNet income4.5B USDfiscal year
31 Dec 2025FinancialsDiluted EPS41.48 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 13.62 USD
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS 12.81 USD
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS 7.27 USD
31 Dec 2024Annual reportFY 2024 reportedEPS 38.34 USD

What is Reddit saying about Regeneron Pharmaceuticals (REGN)?

Reddit mentioned REGN 7 times in the 30 days to 22 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 100% read bullish, 0% bearish and 0% neither. Reddit data updated 22 November 2026.

30-day window, Method

7mentions, 30 days
100%bullish
0%bearish
1communities
+48pointsagainst the market

How do Reddit mentions of Regeneron Pharmaceuticals (REGN) compare with its price?

Share ↗
7 mentions

Which subreddits are talking about Regeneron Pharmaceuticals (REGN)?

30 days

Which subreddits are talking about Regeneron Pharmaceuticals (REGN)?
CommunityShareMentionsNet sentiment
r/wallstreetbets100%7+0.18

What do people ask about Regeneron Pharmaceuticals (REGN)?

From live data
What did Regeneron Pharmaceuticals shares close at?921.31

Regeneron Pharmaceuticals closed at 921.31 USD on 20 Nov 2026, down 0.25% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Regeneron Pharmaceuticals’ market cap?97.9B

Regeneron Pharmaceuticals is worth 97.9B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is Regeneron Pharmaceuticals’ P/E ratio?20.4

Regeneron Pharmaceuticals has a price-to-earnings ratio of 20.4, as of 20 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

What is Regeneron Pharmaceuticals’ revenue?14.3B

Regeneron Pharmaceuticals reported revenue of 14.3B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Regeneron Pharmaceuticals insiders bought or sold shares recently?16 sales

In the 90 days to 23 Nov 2026, Regeneron Pharmaceuticals insiders reported 16 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 10 Aug 2026, show no open-market purchase. A further 17 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own Regeneron Pharmaceuticals?15 of 45

15 of the 45 funds we track reported a Regeneron Pharmaceuticals position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Two Sigma Investments and Citadel Advisors. See Funds

Have members of Congress traded Regeneron Pharmaceuticals?37 trades

Yes. 37 trades in Regeneron Pharmaceuticals appear in the congressional disclosures we hold; the latest is a sale by Gilbert Ray Cisneros, Jr. (House, CA) dated 15 May 2026, filed 8 Jun 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

When did Regeneron Pharmaceuticals last report earnings?18.45

Regeneron Pharmaceuticals last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 18.45 USD; no next date is announced in SEC filings yet. See Filings

Does Regeneron Pharmaceuticals have government contracts?279.4M

Yes. US federal agencies committed 279.4M USD in contracts to it in fiscal 2026, the year to 30 Sep 2026 (USAspending.gov). See Contracts

What is Reddit saying about Regeneron Pharmaceuticals?0 mentions

Regeneron Pharmaceuticals was mentioned 0 times in the last 7 days across the finance subreddits we track, and 7 times over the trailing 30 days. Of the 7 mentions scored for sentiment, 100% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. Wikimedia CommonsPortraits via Wikimedia Commons. Byron Donalds: United States Congress, Public domain; Jefferson Shreve: House Creative Services, Public domain; Robert P. Bresnahan, Jr.: House Creative Services, Public domain; Gilbert Ray Cisneros, Jr.: United States Department of Defense, Public domain.
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
  9. SECSEC fails-to-deliver (CNS) data
  10. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  11. SEC EDGARreported earnings figures and scheduled report dates
  12. SEC EDGARValuation computed from SEC EDGAR filings
  13. Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Regeneron_Pharmaceuticals